Yuhan Corporation

🇰🇷South Korea

Country: 🇰🇷South Korea

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Multi-center, Prospective, Cohort Study to Evaluate the Relationship of Stroke Recurrence and Anti-platelet Resistance in Ischemic Stroke Patients

Completed

Conditions: Ischemic Stroke

First Posted Date: 2019-01-30

Last Posted Date: 2022-10-12

Lead Sponsor: Yuhan Corporation

Target Recruit Count: 1011

Registration Number: NCT03823274

Locations: 🇰🇷
Chungnam National University Hospital, Daejeon, Korea, Republic of

Clinical Trial to Compare the Safety and Pharmacokinetics of YH22162 in Healthy Volunteers

Phase 1

Completed

Conditions: Hypertension

Interventions: Drug: Telmisartan 80mg + Amlodipine 5mg + Chlorthalidone 25mg

First Posted Date: 2018-09-07

Last Posted Date: 2024-11-12

Lead Sponsor: Yuhan Corporation

Target Recruit Count: 67

Registration Number: NCT03662620

Locations: 🇰🇷
Chonbuk National University Hospital, Jeonju, Jeollanam-do, Korea, Republic of

Rosuvastatin/Ezetimibe Versus Rosuvastatin in ASCVD Patients With Type 2 DM

Phase 4

Completed

Conditions: Atherosclerotic Cardiovascular Disease
Type 2 Diabetes Mellitus

Interventions: Drug: Monorova
Drug: Rosuvamibe

First Posted Date: 2018-07-24

Last Posted Date: 2020-12-14

Lead Sponsor: Yuhan Corporation

Target Recruit Count: 236

Registration Number: NCT03597412

Locations: 🇰🇷
Kangbuk Samsung Hospital, Seoul, Korea, Republic of

Clinical Trial to Evaluate the Safety and Effects of Ethnicity and Food on Pharmacokinetics of YH25448

Phase 1

Completed

Conditions: Non-Small Cell Lung Cancer

Interventions: Drug: YH25448 240mg

First Posted Date: 2018-06-14

Last Posted Date: 2019-01-16

Lead Sponsor: Yuhan Corporation

Target Recruit Count: 24

Registration Number: NCT03556436

Locations: 🇰🇷
Seoul National University Hospital Clinical Trial Center, Seoul, Korea, Republic of

HMG-CoA Reductase add-on in Chronic Kidney Disease Patients With Proteinuria

Phase 4

Conditions: Chronic Kidney Disease
Proteinuria

Interventions: Drug: Telmisartan 40mg
Drug: Telmisartan/Rosuvastatin 40/10mg

First Posted Date: 2018-06-08

Last Posted Date: 2020-12-14

Lead Sponsor: Yuhan Corporation

Target Recruit Count: 374

Registration Number: NCT03550859

Locations: 🇰🇷
Hallym University Sacred Heart Hospital, Anyang, Gyeonggi-do, Korea, Republic of
🇰🇷
Seoul National University Bundang Hospital, Seongnam, Gyeonggi-do, Korea, Republic of
🇰🇷
Chonbuk National University Hospital, Jeonju, Jeollabuk-do, Korea, Republic of

and more 13 locations

A Study to Evaluate the Effect of Sarpogrelate on Blood Hyperviscosity

Phase 4

Completed

Conditions: Peripheral Artery Disease, PAD

Interventions: Drug: Anplag Tab. 100mg bid
Drug: Anplag Tab. 100mg tid

First Posted Date: 2018-04-26

Last Posted Date: 2020-06-23

Lead Sponsor: Yuhan Corporation

Target Recruit Count: 60

Registration Number: NCT03509922

Locations: 🇰🇷
The Catholic University of Korea, Uijeongbu ST. Mary's Hospital, Uijeongbu, Gyeonggido, Korea, Republic of

High-intensity Rosuvastatin and Moderate-intensity Rosuvastatin/Ezetimibe in ASCVD Patients

Phase 4

Completed

Conditions: ASCVD

Interventions: Drug: Monorova
Drug: Rosuvamibe

First Posted Date: 2018-04-11

Last Posted Date: 2019-12-30

Lead Sponsor: Yuhan Corporation

Target Recruit Count: 270

Registration Number: NCT03494270

Locations: 🇰🇷
Seoul National University Bundang Hospital, Seongnam, Korea, Republic of

High-Dose Statin Combined With Telmisartan vs Amlodipine on Glucose Metabolism in ASCVD Patients With IFG and Hypertension

Phase 4

Completed

Conditions: Hypertension
ASCVD
Impaired Fasting Glucose

Interventions: Drug: Monorova® + Amlopin®
Drug: Duowell®

First Posted Date: 2018-03-22

Last Posted Date: 2021-06-02

Lead Sponsor: Yuhan Corporation

Target Recruit Count: 100

Registration Number: NCT03474562

Locations: 🇰🇷
Severance Hospital, Seoul, Korea, Republic of
🇰🇷
Dankook University Hospital, Cheonan, Korea, Republic of
🇰🇷
CHA Bundang Medical Center, Seongnam-si, Gyeonggi-do, Korea, Republic of

and more 1 locations

Rosuvastatin/Ezetimibe vs Rosuvastatin in Korean Patients With Type 2 Diabetes Mellitus and Hypercholesterolemia

Phase 4

Completed

Conditions: Type 2 Diabetes Mellitus
Hypercholesterolemia

Interventions: Drug: Rosuvamibe® Tab
Drug: Monorova® Tab

First Posted Date: 2018-02-26

Last Posted Date: 2019-07-23

Lead Sponsor: Yuhan Corporation

Target Recruit Count: 140

Registration Number: NCT03446261

Locations: 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of

Effect of Choline Alphoscerate on Cognitive Function in Alzheimer's Dementia

Phase 4

Conditions: Alzheimer's Disease

Interventions: Drug: Alfoatirin® Tab. + Aripezil® Tab.
Drug: Aripezil® Tab.

First Posted Date: 2018-02-22

Last Posted Date: 2020-12-22

Lead Sponsor: Yuhan Corporation

Target Recruit Count: 79

Registration Number: NCT03441516

Locations: 🇰🇷
Dong-A University Hospital, Busan, Korea, Republic of
🇰🇷
Gyeongsang National University Hospital, Busan, Korea, Republic of
🇰🇷
Inje University Busan Paik Hospital, Busan, Korea, Republic of

and more 3 locations

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy